The main products that can be purchased in China are capsules, tablets and granules produced by two companies, Japan's Miya and Qingdao Donghai. Ataining is just the trade name of the drug, which is Clostridium butyricum live bacteria capsules produced by Qingdao Donghai Pharmaceutical. The common live preparations of Clostridium butyricum currently produced in China include powders, tablets and capsules.
Tablets: oral Clostridium butyricum live bacteria tablets produced by Japan Mialisan Pharmaceutical Co., Ltd.; Chang Lining (i.e. Clostridium butyricum live bacteria tablets) produced by Qingdao Donghai Pharmaceutical Co., Ltd.
Powder: Baolaan (clostridium butyricum live bacteria powder) produced by Qingdao Donghai Pharmaceutical Co., Ltd., Miya (oral live Clostridium butyricum powder) produced by Japan Miyalisan Pharmaceutical Co., Ltd.
In addition, there are granules, etc.
The manufacturer of Clostridium butyricum live bacteria capsules (Ataining) is Qingdao Donghai Pharmaceutical Co., Ltd., approval number: S20040084.
Qingdao Donghai Pharmaceutical Co., Ltd. was established on August 8, 2003. It is an outstanding enterprise in my country's microecological industry. The company insists on taking the benefit of people's health as its own responsibility, and independently develops a series of new microecological drugs such as Baolean, Ataining, Shuangshubao, and Changlining, which solve the problems of IBS, chronic diarrhea, ulcers, neonatal jaundice, eczema, etc. Due to the lack of effective treatments for various chronic diseases caused by intestinal flora imbalance, he has applied for more than 60 national patents and obtained 2 U.S. new drug invention patents. Donghai Pharmaceutical successfully isolated and obtained my country's medicinal Clostridium butyricum (CGMCC313.1) and Bacillus coagulans (TBC-169) strains; and overcame key technical problems such as high-density fermentation technology and normal temperature storage and transportation technology, making my country one of the world's leading pharmaceutical companies. As a country that has mastered this technology, China’s probiotic production technology has attracted worldwide attention.
The Clostridium butyricum live bacteria capsules produced by Donghai Pharmaceutical are packaged in 420mg*30s and are valid for 24 months. Clostridium butyricum live bacteria capsules are capsules, and the contents are white or off-white powder with gray-yellow spots in between. It has a slightly special smell and a sweet taste. Clostridium butyricum live bacteria capsules are taken orally, for adults, 3 capsules at a time, 2 times a day. For acute diarrhea, the treatment course is 3 to 7 days; for chronic diarrhea, the treatment course is 14 to 21 days. Clostridium butyricum live bacteria capsules can withstand gastric acid entering the intestines, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestines. It can also promote the growth of beneficial intestinal bacteria such as Bifidobacteria. Therefore, Clostridium butyricum live bacteria capsules have a certain repair effect on the intestinal tract, and the side effects will not be obvious, so patients can use it with confidence.